• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

[A comparison of the time of in vivo resistance development of tubercle bacilli to rifampicin, kanamycin, ethionamide, lividomycin, and enviomycin (tuberactinomycin-N) in patients with chronic cavitary tuberculosis (author's transl)].

作者信息

Tsukamura M

出版信息

Kekkaku. 1978 Oct;53(10):495-8.

PMID:102861
Abstract
摘要

相似文献

1
[A comparison of the time of in vivo resistance development of tubercle bacilli to rifampicin, kanamycin, ethionamide, lividomycin, and enviomycin (tuberactinomycin-N) in patients with chronic cavitary tuberculosis (author's transl)].慢性空洞型肺结核患者体内结核杆菌对利福平、卡那霉素、乙硫异烟胺、青紫霉素和恩维霉素（结核放线菌素 - N）产生耐药性的时间比较（作者译）
Kekkaku. 1978 Oct;53(10):495-8.
2
[Critical concentrations for resistances of tubercle bacilli to tuberactinomycin-N, viomycin, capreomycin, and lividomycin in patients treated with these agents (cross-resistance-relationships among resistances to aminoglucoside-antibiotics found during chemotherapy for tuberculosis) (author's transl)].使用结核放线菌素-N、紫霉素、卷曲霉素和青紫霉素治疗的患者中结核杆菌对这些药物的耐药临界浓度（在结核病化疗期间发现的对氨基糖苷类抗生素耐药之间的交叉耐药关系）（作者译）
Kekkaku. 1975 May;50(4-5):123-30.
3
[Cases of pulmonary tuberculosis in which kanamycin-resistant tubercle bacilli did not appear even after a long-term administration of kanamycin. Some consideration on the interpretation of drug resistance tests].[长期使用卡那霉素后仍未出现耐卡那霉素结核杆菌的肺结核病例。关于耐药性试验结果解读的一些思考]
Kekkaku. 1971 Oct;46(10):405-8.
4
[Clinical effects of rifampicin for pulmonary tuberculosis patients. 2. Results of rifampicin treatment for advanced pulmonary tuberculosis patients resistant to conventional antituberculous drugs].
Kekkaku. 1971 Nov;46(11):423-8.
5
[Drug resistance of tubercle bacilli -- from the clinical point of view (author's transl)].
Kekkaku. 1976 Dec;51(12):477-87.
6
[Evolution of antibiograms of bacilli persisting under treatment in the sanatorium].
Rev Tuberc Pneumol (Paris). 1967 Sep-Oct;31(6):785-808.
7
Cross-resistant relationships among the aminoglucoside antibiotics in Mycobacterium tuberculosis.结核分枝杆菌中氨基糖苷类抗生素之间的交叉耐药关系。
J Gen Microbiol. 1975 Jun;88(2):269-74. doi: 10.1099/00221287-88-2-269.
8
The treatment of drug resistant chronic pulmonary tuberculosis with new tuberculostatics.
Bull Int Union Tuberc. 1968 Dec;41:194-200.
9
[Kanamycin and florimycin in the clinical course of pulmonary tuberculosis].
Antibiotiki. 1971 Feb;16(2):184-8.
10
[Cross resistance of tubercle bacilli to KM, VM, CPM, LVM and TUM. I. The sensitivity of human tubercle bacilli isolated from patients to the five antibiotics (author's transl)].
Kekkaku. 1974 Mar;49(3):57-61.

引用本文的文献

1
The chemical biology of new drugs in the development for tuberculosis.新药研发中的结核病化学生物学。
Curr Opin Chem Biol. 2010 Aug;14(4):456-66. doi: 10.1016/j.cbpa.2010.04.008. Epub 2010 May 7.